Dose-Ranging Study of the Bimatoprost Ocular Insert
Status:
Completed
Trial end date:
2015-10-07
Target enrollment:
Participant gender:
Summary
The Bimatoprost Ocular Insert is intended to provide sustained delivery of bimatoprost to the
ocular surface to lower the intraocular pressure (IOP) in patients with Open-Angle Glaucoma
or Ocular Hypertension.
This study evaluated the safety and efficacy of two different doses of the Bimatoprost Ocular
Insert, compared to an active control arm with timolol ophthalmic solution (0.5%).